1. Valuation Metrics (Score: 8/10) P/E Ratio: Pfizer’s trailing and forward P/E ratios are relatively low compared to many peers in big pharma, but keep ...
1. Valuation Metrics (Score: 8/10) P/E Ratio: Pfizer’s trailing and forward P/E ratios are relatively low compared to many peers in big pharma, but keep ...